Hepatitis C Virus (HCV) Infection Terminated Phase 2 Trials for Nivocasan (DB12720)

Also known as: Hepatitis C (HCV) / HCV Infection / HCV Infections / HCV / Hepatits C / Hepatitis C Virus (HCV) / Hepatitis C Virus / Hepatitis C virus test

IndicationStatusPhase
DBCOND0052122 (Hepatitis C Virus (HCV) Infection)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00874796Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus InfectionTreatment